
|Articles|February 1, 2017
- Applied Clinical Trials-02-01-2017
- Volume 26
- Issue 2
Applied Clinical Trials, February/March 2017 Issue (PDF)
Click the title above to open the Applied Clinical Trials February/March 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Investigators’ Financial Ties Come Under Close Scrutinyalmost 9 years ago
Times Changing for Ethics Guidelines, tooalmost 9 years ago
Disruptive Innovation and the Technology Strategies Neededalmost 9 years ago
Searching for Innovation in Researchalmost 9 years ago
Measuring Adoption and Value of Patient Engagementalmost 9 years ago
How We Get to the Engaged Patientalmost 9 years ago
A Practical Overview of Patient-Centric Trialsalmost 9 years ago
Improving Patient Engagement through eCOAalmost 9 years ago
An Auditor’s View of Compliance ChallengesNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
4
Using AI and Tokenized Data to Match Patients to Protocols
5





.png)



.png)



.png)
.png)
